Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer

SIMPLE SUMMARY: Alpelisib is a drug used to treat breast cancer that has certain characteristics (hormone receptor-positive (HR+), human epidermal growth receptor 2-negative (HER2–), PIK3CA-mutated) and that has or has not spread to other organs. It is used after the cancer has progressed despite be...

Descripción completa

Detalles Bibliográficos
Autores principales: Tankova, Tsvetalina, Senkus, Elżbieta, Beloyartseva, Maria, Borštnar, Simona, Catrinoiu, Doina, Frolova, Mona, Hegmane, Alinta, Janež, Andrej, Krnić, Mladen, Lengyel, Zoltan, Marcou, Yiola, Mazilu, Laura, Mrinakova, Bela, Percik, Ruth, Petrakova, Katarina, Rubovszky, Gábor, Tokar, Margarita, Vrdoljak, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997133/
https://www.ncbi.nlm.nih.gov/pubmed/35406370
http://dx.doi.org/10.3390/cancers14071598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997133/
https://www.ncbi.nlm.nih.gov/pubmed/35406370
http://dx.doi.org/10.3390/cancers14071598

Ejemplares similares